Anti-fibrillary and anti-adrenaline activity of beta-receptor blocking drugs.
D000813:Anilides / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001281:Atrial Fibrillation / Q000188:drug therapy; D002415:Cats; D004837:Epinephrine / Q000037:antagonists & inhibitors*; D004983:Ethanolamines / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D006325:Heart Atria / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology; D008012:Lidocaine / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D009121:Muscle Denervation / Q000187:drug effects; D009132:Muscles / Q000187:drug effects*; D009991:Oscillometry; D011342:Procainamide / Q000494:pharmacology; D011343:Procaine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D011817:Rabbits; D012601:Scopolamine / Q000494:pharmacology; D013450:Sulfones / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D004983:Ethanolamines; D013450:Sulfones; D013565:Sympatholytics; D011343:Procaine; D008012:Lidocaine; D011433:Propranolol; D012601:Scopolamine; D008729:Methoxamine; D011802:Quinidine; D011342:Procainamide; D007545:Isoproterenol; D004837:Epinephrine; D006145:Guanethidine